Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
MongoDB Needs to Show AI Uplift Potential for Re-Rating of Stock, UBS Says

MongoDB Needs to Show AI Uplift Potential for Re-Rating of Stock, UBS Says

MT newswireMT newswire2026/10/01 16:51
12:51 PM EDT, 10/01/2026 (MT Newswires) -- MongoDB (MDB) needs to demonstrate "material AI uplift potential" for a re-rating of the stock, UBS said in a note emailed Thursday that featured feedback from current customers. During its investor day, the company stated that the impact of artificial intelligence on its revenue growth was "still small," and customer feedback supported this assertion, UBS analysts said. Very few customers are running AI-centric workloads on the platform at present, with one customer sharing a use case that was "too lightweight" to have a significant impact on spending, the analysts noted. Uptake on the company's core products leans more positive, with no signs indicating any spending downturn or material negative, the analysts said. Feedback from customers using Atlas in the cloud and EA on-prem were mostly upbeat, according to the note. UBS' rating on the company's stock is neutral with a price target of $375. Price: 354.14, Change: +5.52, Percent Change: +1.58
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Hulamin says Paul Baloyi resigns as independent non-executive director

Hulamin said independent non-executive director Paul Baloyi resigned, effective Oct. 2, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hulamin Ltd. published the original content used to generate this news brief via SENS, the regulatory disclosure system operated by the Johannesburg Securities Exchange (JSE) (Ref. ID: S604350), on October 05, 2026, and is solely responsible for the information contained therein.

Bitget•2026/10/05 14:30

US Stock Move | Pneumococcal vaccine achieves late-stage clinical trial target, Vaxcyte (PCVX.US) opens more than 50% higher

On Monday, Vaxcyte (PCVX.US) soared more than 50% at the open and was up approximately 53% at the time of writing, with a market capitalization of 12.8 billions USD.

智通财经•2026/10/05 13:47